Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Guangdong Zhongsheng Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.00 Million ≈ $12.88 Million USD) by net assets (CN¥4.13 Billion ≈ $603.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Cash flow conversion efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. This chart illustrates how Guangdong Zhongsheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Guangdong Zhongsheng Pharmaceutical Co L for real-time trading data and today's change.
Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Guangdong Zhongsheng Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangdong Zhongsheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Zhongsheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 002317 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Capital Co Ltd
SHG:600008
|
0.023x |
|
MiTAC Holdings Corp
TW:3706
|
0.045x |
|
IGB Real Estate Investment Trust
KLSE:5227
|
0.027x |
|
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
|
0.004x |
|
Sejong Telecom Inc
KQ:036630
|
0.017x |
|
Levima Advanced Materials Corp
SHE:003022
|
0.039x |
|
Constellium SE
F:3OK
|
0.128x |
|
WisdomTree Inc.
NYSE:WT
|
0.180x |
Annual Cash Flow Conversion Efficiency for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. Review 002317 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.01 Billion ≈ $586.81 Million |
CN¥337.84 Million ≈ $49.44 Million |
0.084x | +100.03% |
| 2023-12-31 | CN¥4.53 Billion ≈ $662.25 Million |
CN¥190.61 Million ≈ $27.89 Million |
0.042x | +154.87% |
| 2022-12-31 | CN¥3.82 Billion ≈ $558.47 Million |
CN¥63.07 Million ≈ $9.23 Million |
0.017x | -90.61% |
| 2021-12-31 | CN¥3.54 Billion ≈ $517.74 Million |
CN¥622.77 Million ≈ $91.13 Million |
0.176x | +359.44% |
| 2020-12-31 | CN¥3.63 Billion ≈ $530.67 Million |
CN¥138.93 Million ≈ $20.33 Million |
0.038x | -36.93% |
| 2019-12-31 | CN¥4.13 Billion ≈ $605.00 Million |
CN¥251.16 Million ≈ $36.75 Million |
0.061x | -26.56% |
| 2018-12-31 | CN¥3.95 Billion ≈ $578.14 Million |
CN¥326.78 Million ≈ $47.82 Million |
0.083x | -16.59% |
| 2017-12-31 | CN¥3.73 Billion ≈ $545.87 Million |
CN¥369.91 Million ≈ $54.13 Million |
0.099x | +0.37% |
| 2016-12-31 | CN¥3.42 Billion ≈ $501.07 Million |
CN¥338.28 Million ≈ $49.50 Million |
0.099x | +8.41% |
| 2015-12-31 | CN¥2.11 Billion ≈ $308.69 Million |
CN¥192.25 Million ≈ $28.13 Million |
0.091x | +72.01% |
| 2014-12-31 | CN¥1.90 Billion ≈ $277.85 Million |
CN¥100.60 Million ≈ $14.72 Million |
0.053x | -16.77% |
| 2013-12-31 | CN¥1.74 Billion ≈ $255.05 Million |
CN¥110.95 Million ≈ $16.23 Million |
0.064x | -29.06% |
| 2012-12-31 | CN¥1.59 Billion ≈ $232.18 Million |
CN¥142.38 Million ≈ $20.83 Million |
0.090x | +87.87% |
| 2011-12-31 | CN¥1.48 Billion ≈ $216.16 Million |
CN¥70.56 Million ≈ $10.32 Million |
0.048x | -27.79% |
| 2010-12-31 | CN¥1.39 Billion ≈ $202.91 Million |
CN¥91.72 Million ≈ $13.42 Million |
0.066x | -15.09% |
| 2009-12-31 | CN¥1.30 Billion ≈ $189.52 Million |
CN¥100.89 Million ≈ $14.76 Million |
0.078x | -81.57% |
| 2008-12-31 | CN¥172.40 Million ≈ $25.23 Million |
CN¥72.86 Million ≈ $10.66 Million |
0.423x | +11.80% |
| 2007-12-31 | CN¥130.56 Million ≈ $19.11 Million |
CN¥49.35 Million ≈ $7.22 Million |
0.378x | +192.84% |
| 2006-12-31 | CN¥138.72 Million ≈ $20.30 Million |
CN¥17.91 Million ≈ $2.62 Million |
0.129x | -- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.